Daiichi Sankyo Deutschland
Sonstige
Our company was founded in Europe in 2006 through the merger of the well-established Japanese companies Daiichi and Sankyo. Daiichi Sankyo is a global pharmaceutical company headquartered in Japan with a presence in more than 20 countries worldwide. With over 100 years of scientific expertise, we have pioneered several leading medicines that have improved the lives of countless people. We are committed to supporting patients with cardiovascular diseases through innovative therapies. Since 2002, our cardiovascular therapies have improved treatment outcomes for more than 40 million* patients across Europe.
